A surging demand for blood products is drawing the world’s largest suppliers in China, where supplies are limited by strict rules governing blood donation.

Shutting down ports of entry at the U.S.-Mexico border near San Diego could cost local industry billions, say business officials in the region.

Drones will take delicate drugs to dozens of remote villages in a test that could be replicated around the world.

A common theme this earnings season: U.S. business executives are ready to relocate their supply chains if the cost of importing Chinese goods becomes prohibitive.

China might be closing its wallet to some high-profile U.S. exports as part of the ongoing trade war, but it's wide open to others.

As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.

Certain shifts in business strategy seem so shockingly obvious in retrospect that you have to wonder why they weren’t common practice all along.